현재 위치：홈 > 뉴스현황 > Market Activity > (DRUG DISCOVERY 2021...
저자：medicilon 업로드：2021-10-18 조회수：
19-20 Oct. 2021, Medicilon welcomes you to join us at Europe’s largest meeting for life sciences industry professionals, ELRIG’s annual Drug Discovery meeting .
This year, Drug Discovery 2021 promises to be particularly special event, providing a platform for the whole drug discovery community to meet at a free to attend, in-person event, where members of ELRIG’s community may:
Re-connect with colleagues, as well as hear stories from scientists who have been responsible for combatting COVID-19 in the session tracks on infection and diagnostics.
Re-invent the process of drug discovery, by building diverse partnerships with even greater emphasis on efficiency, automation, and remote operation in our two session tracks of screening and chemistry.
Re-imagine and create a new vision for drug discovery, with insights from our innovation and disruptive strategies tracks.
Medicilon looks forward to meeting you at Booth #F15. With more than 17 years of experience in preclinical R&D, we’d like to build partnership with you and assist your drug R&D projects in:
From its inception in 2004, Shanghai Medicilon Inc. (STAR Market stock code: 688202.SH) has been committed to providing comprehensive research and development (R&D) services to pharmaceutical companies, research institutions, and any organizations working in the preclinical space, with the primary objective of supporting and accelerating pharmaceutical, biopharmaceutical R&D worldwide.
